Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 3
1957 1
1959 4
1960 1
1962 1
1963 2
1964 1
1965 3
1966 2
1968 2
1969 2
1971 3
1972 3
1973 1
1974 4
1975 3
1976 5
1977 7
1978 2
1979 6
1980 5
1981 9
1982 14
1983 7
1984 9
1985 8
1986 14
1987 5
1988 5
1989 6
1990 6
1991 13
1992 9
1993 8
1994 6
1995 5
1996 14
1997 11
1998 7
1999 14
2000 7
2001 8
2002 14
2003 13
2004 12
2005 4
2006 10
2007 6
2008 8
2009 6
2010 2
2011 6
2012 8
2013 8
2014 11
2015 5
2016 8
2017 10
2018 15
2019 23
2020 39
2021 24
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

467 results
Results by year
Filters applied: . Clear all
Page 1
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Freeman-Cook K, et al. Among authors: nagata a. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. Cancer Cell. 2021. PMID: 34520734
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.
Freeman-Cook KD, Hoffman RL, Behenna DC, Boras B, Carelli J, Diehl W, Ferre RA, He YA, Hui A, Huang B, Huser N, Jones R, Kephart SE, Lapek J, McTigue M, Miller N, Murray BW, Nagata A, Nguyen L, Niessen S, Ninkovic S, O'Doherty I, Ornelas MA, Solowiej J, Sutton SC, Tran K, Tseng E, Visswanathan R, Xu M, Zehnder L, Zhang Q, Zhang C, Dann S. Freeman-Cook KD, et al. Among authors: nagata a. J Med Chem. 2021 Jul 8;64(13):9056-9077. doi: 10.1021/acs.jmedchem.1c00159. Epub 2021 Jun 10. J Med Chem. 2021. PMID: 34110834
Synthetic Chemical Probes That Dissect Vitamin D Activities.
Nagata A, Akagi Y, Asano L, Kotake K, Kawagoe F, Mendoza A, Masoud SS, Usuda K, Yasui K, Takemoto Y, Kittaka A, Nagasawa K, Uesugi M. Nagata A, et al. ACS Chem Biol. 2019 Dec 20;14(12):2851-2858. doi: 10.1021/acschembio.9b00718. Epub 2019 Oct 28. ACS Chem Biol. 2019. PMID: 31618573
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance.
Chen P, Lee NV, Hu W, Xu M, Ferre RA, Lam H, Bergqvist S, Solowiej J, Diehl W, He YA, Yu X, Nagata A, VanArsdale T, Murray BW. Chen P, et al. Among authors: nagata a. Mol Cancer Ther. 2016 Oct;15(10):2273-2281. doi: 10.1158/1535-7163.MCT-16-0300. Epub 2016 Aug 5. Mol Cancer Ther. 2016. PMID: 27496135
Controlled lipid β-oxidation and carnitine biosynthesis by a vitamin D metabolite.
Mendoza A, Takemoto Y, Cruzado KT, Masoud SS, Nagata A, Tantipanjaporn A, Okuda S, Kawagoe F, Sakamoto R, Odagi M, Mototani S, Togashi M, Kawatani M, Aono H, Osada H, Nakagawa H, Higashi T, Kittaka A, Nagasawa K, Uesugi M. Mendoza A, et al. Among authors: nagata a. Cell Chem Biol. 2022 Apr 21;29(4):660-669.e12. doi: 10.1016/j.chembiol.2021.08.008. Epub 2021 Sep 9. Cell Chem Biol. 2022. PMID: 34506728
Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nagata A, Nasu M, Kaida Y, Nakayama Y, Kurokawa Y, Nakamura N, Shibata R, Hazama T, Tsukimura T, Togawa T, Saito S, Sakuraba H, Fukami K. Nagata A, et al. Nephrol Dial Transplant. 2021 Dec 31;37(1):115-125. doi: 10.1093/ndt/gfaa324. Nephrol Dial Transplant. 2021. PMID: 34282462 Free PMC article.
[Diastema].
Nagata A. Nagata A. Shiyo. 1985 Sep;33(9):761-3. Shiyo. 1985. PMID: 3866887 Japanese. No abstract available.
467 results